首页 > 最新文献

Journal of Venomous Animals and Toxins Including Tropical Diseases最新文献

英文 中文
Pulmonary involvement from animal toxins: the cellular mechanisms. 动物毒素对肺部的影响:细胞机制。
IF 1.8 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-09-18 eCollection Date: 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2023-0026
Suthimon Thumtecho, Suchai Suteparuk, Visith Sitprija

Venomous animals and their venom have always been of human interest because, despite species differences, coevolution has made them capable of targeting key physiological components of our bodies. Respiratory failure from lung injury is one of the serious consequences of envenomation, and the underlying mechanisms are rarely discussed. This review aims to demonstrate how toxins affect the pulmonary system through various biological pathways. Herein, we propose the common underlying cellular mechanisms of toxin-induced lung injury: interference with normal cell function and integrity, disruption of normal vascular function, and provocation of excessive inflammation. Viperid snakebites are the leading cause of envenomation-induced lung injury, followed by other terrestrial venomous animals such as scorpions, spiders, and centipedes. Marine species, particularly jellyfish, can also inflict such injury. Common pulmonary manifestations include pulmonary edema, pulmonary hemorrhage, and exudative infiltration. Severe envenomation can result in acute respiratory distress syndrome. Pulmonary involvement suggests severe envenomation, thus recognizing these mechanisms and manifestations can aid physicians in providing appropriate treatment.

毒液动物及其毒液一直引起人类的兴趣,因为尽管存在物种差异,但共同进化使它们能够针对我们身体的关键生理成分。肺损伤引起的呼吸衰竭是环境恶化的严重后果之一,其潜在机制很少被讨论。这篇综述旨在证明毒素如何通过各种生物途径影响肺部系统。在此,我们提出了毒素诱导的肺损伤的常见潜在细胞机制:干扰正常细胞功能和完整性、破坏正常血管功能和引发过度炎症。毒蛇咬伤是环境致肺损伤的主要原因,其次是其他陆生有毒动物,如蝎子、蜘蛛和蜈蚣。海洋物种,尤其是水母,也会造成这种伤害。常见的肺部表现包括肺水肿、肺出血和渗出性浸润。严重的环境污染可导致急性呼吸窘迫综合征。肺部受累意味着严重的环境恶化,因此认识到这些机制和表现可以帮助医生提供适当的治疗。
{"title":"Pulmonary involvement from animal toxins: the cellular mechanisms.","authors":"Suthimon Thumtecho, Suchai Suteparuk, Visith Sitprija","doi":"10.1590/1678-9199-JVATITD-2023-0026","DOIUrl":"10.1590/1678-9199-JVATITD-2023-0026","url":null,"abstract":"<p><p>Venomous animals and their venom have always been of human interest because, despite species differences, coevolution has made them capable of targeting key physiological components of our bodies. Respiratory failure from lung injury is one of the serious consequences of envenomation, and the underlying mechanisms are rarely discussed. This review aims to demonstrate how toxins affect the pulmonary system through various biological pathways. Herein, we propose the common underlying cellular mechanisms of toxin-induced lung injury: interference with normal cell function and integrity, disruption of normal vascular function, and provocation of excessive inflammation. Viperid snakebites are the leading cause of envenomation-induced lung injury, followed by other terrestrial venomous animals such as scorpions, spiders, and centipedes. Marine species, particularly jellyfish, can also inflict such injury. Common pulmonary manifestations include pulmonary edema, pulmonary hemorrhage, and exudative infiltration. Severe envenomation can result in acute respiratory distress syndrome. Pulmonary involvement suggests severe envenomation, thus recognizing these mechanisms and manifestations can aid physicians in providing appropriate treatment.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20230026"},"PeriodicalIF":1.8,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41123335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Snake venom disintegrins update: insights about new findings. 蛇毒崩解剂更新:关于新发现的见解。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-09-18 eCollection Date: 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2023-0039
Gabriela de Oliveira Almeida, Isadora Sousa de Oliveira, Eliane Candiani Arantes, Suely Vilela Sampaio

Snake venom disintegrins are low molecular weight, non-enzymatic proteins rich in cysteine, present in the venom of snakes from the families Viperidae, Crotalidae, Atractaspididae, Elapidae, and Colubridae. This family of proteins originated in venom through the proteolytic processing of metalloproteinases (SVMPs), which, in turn, evolved from a gene encoding an A Disintegrin And Metalloprotease (ADAM) molecule. Disintegrins have a recognition motif for integrins in their structure, allowing interaction with these transmembrane adhesion receptors and preventing their binding to proteins in the extracellular matrix and other cells. This interaction gives disintegrins their wide range of biological functions, including inhibition of platelet aggregation and antitumor activity. As a result, many studies have been conducted in an attempt to use these natural compounds as a basis for developing therapies for the treatment of various diseases. Furthermore, the FDA has approved Tirofiban and Eptifibatide as antiplatelet compounds, and they are synthesized from the structure of echistatin and barbourin, respectively. In this review, we discuss some of the main functional and structural characteristics of this class of proteins and their potential for therapeutic use.

蛇毒崩解蛋白是一种低分子量、富含半胱氨酸的非酶蛋白,存在于毒蛇科、克氏蛇科、白术蛇科、蛇科和蛇科的毒液中。这一蛋白质家族通过金属蛋白酶(SVMP)的蛋白水解过程起源于毒液,而金属蛋白酶又是由编码分解蛋白和金属蛋白酶(ADAM)分子的基因进化而来的。崩解蛋白在其结构中具有整合素的识别基序,允许与这些跨膜粘附受体相互作用,并阻止它们与细胞外基质和其他细胞中的蛋白质结合。这种相互作用赋予崩解剂广泛的生物学功能,包括抑制血小板聚集和抗肿瘤活性。因此,已经进行了许多研究,试图将这些天然化合物作为开发治疗各种疾病的疗法的基础。此外,美国食品药品监督管理局已批准替罗非班和依替非肽为抗血小板化合物,它们分别由埃奇他汀和巴博林的结构合成。在这篇综述中,我们讨论了这类蛋白质的一些主要功能和结构特征及其治疗应用的潜力。
{"title":"Snake venom disintegrins update: insights about new findings.","authors":"Gabriela de Oliveira Almeida,&nbsp;Isadora Sousa de Oliveira,&nbsp;Eliane Candiani Arantes,&nbsp;Suely Vilela Sampaio","doi":"10.1590/1678-9199-JVATITD-2023-0039","DOIUrl":"10.1590/1678-9199-JVATITD-2023-0039","url":null,"abstract":"<p><p>Snake venom disintegrins are low molecular weight, non-enzymatic proteins rich in cysteine, present in the venom of snakes from the families Viperidae, Crotalidae, Atractaspididae, Elapidae, and Colubridae. This family of proteins originated in venom through the proteolytic processing of metalloproteinases (SVMPs), which, in turn, evolved from a gene encoding an A Disintegrin And Metalloprotease (ADAM) molecule. Disintegrins have a recognition motif for integrins in their structure, allowing interaction with these transmembrane adhesion receptors and preventing their binding to proteins in the extracellular matrix and other cells. This interaction gives disintegrins their wide range of biological functions, including inhibition of platelet aggregation and antitumor activity. As a result, many studies have been conducted in an attempt to use these natural compounds as a basis for developing therapies for the treatment of various diseases. Furthermore, the FDA has approved Tirofiban and Eptifibatide as antiplatelet compounds, and they are synthesized from the structure of echistatin and barbourin, respectively. In this review, we discuss some of the main functional and structural characteristics of this class of proteins and their potential for therapeutic use.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20230039"},"PeriodicalIF":2.4,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561651/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41204240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Taiwan cobra envenoming: serum venom concentration before and after specific treatment and relationship with debridement of necrotic wound tissue. 台湾眼镜蛇中毒:特定治疗前后血清毒液浓度及其与坏死伤口组织清创的关系。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2022-0027
Chia-Cheng Wang, Chun-Hsiang Ou Yang, Chih-Po Hsu, Chien-Chun Liu, Jau-Song Yu, Chih-Hong Lo, Wen-Chih Fann, Yen-Chia Chen, Chih Chuan Lin

Background: Bivalent freeze-dried neurotoxic (FN) antivenom has been the primary treatment since the 1980s for Taiwan cobra (Naja atra) envenomation in Taiwan. However, envenomation-related wound necrosis is a significant problem after cobra snakebites. In the present study, we analyzed the changes in serum venom concentration before and after antivenom administration to discover their clinical implications and the surgical treatment options for wound necrosis.

Methods: The patients were divided into limb swelling and wound necrosis groups. The clinical outcome was that swelling started to subside 12 hours after antivenom treatment in the first group. Serum venom concentrations before and after using antivenoms were measured to assess the antivenom's ability to neutralize the circulating cobra venom. The venom levels in wound wet dressing gauzes, blister fluids, and debrided tissues were also investigated to determine their clinical significance. We also observed the evolutional changes of wound necrosis and chose a better wound debridement timing.

Results: We prospectively enrolled 15 Taiwan cobra snakebite patients. Males accounted for most of this study population (n = 11, 73%). The wound necrosis group received more antivenom doses than the limb swelling group (4; IQR:2-6 vs 1; IQR:1-2, p = 0.05), and less records of serum venom concentrations changed before/after antivenom use (p = 0.0079). The necrotic wound site may release venom into circulation and cause more severe envenomation symptoms. Antivenom can efficiently diminish limb swelling in cobra bite patients. However, antivenom cannot reduce wound necrosis. Patients with early debridement of wound necrosis had a better limb outcome, while late or without debridement may have long-term hospital stay and distal limb morbidity.

Conclusions: Antivenom can efficiently eliminate the circulating cobra venom in limb swelling patients without wound necrosis. Early debridement of the bite site wound and wet dressing management are suggestions for preventing extended tissue necrosis and hospital stay.

背景:自1980年代以来,二价冻干神经毒抗蛇毒一直是台湾眼镜蛇(Naja atra)中毒的主要治疗方法。然而,在眼镜蛇咬伤后,与毒液相关的伤口坏死是一个重大问题。在本研究中,我们分析了抗蛇毒血清给药前后血清毒液浓度的变化,以发现其临床意义和伤口坏死的手术治疗选择。方法:将患者分为肢体肿胀组和创面坏死组。临床结果是第一组抗蛇毒血清治疗12小时后肿胀开始消退。在使用抗蛇毒血清前后测量血清毒液浓度,以评估抗蛇毒血清中和循环眼镜蛇毒液的能力。还研究了伤口湿敷料、水泡液和清创组织中的毒液水平,以确定其临床意义。观察创面坏死的进化变化,选择较好的创面清创时机。结果:前瞻性纳入15例台湾眼镜蛇咬伤患者。男性占本研究人群的大部分(n = 11,73%)。创面坏死组抗蛇毒血清剂量高于肢体肿胀组(4;IQR:2-6 vs 1;IQR:1-2, p = 0.05),使用抗蛇毒血清前后血清毒液浓度变化记录较少(p = 0.0079)。坏死的伤口部位可能释放毒液进入血液循环,引起更严重的中毒症状。抗蛇毒血清能有效地减轻眼镜蛇咬伤患者的肢体肿胀。然而,抗蛇毒血清不能减少伤口坏死。早期清创创面坏死患者的肢体预后较好,而晚清创或不清创可能导致长期住院和远端肢体并发症。结论:抗蛇毒血清能有效清除无伤口坏死的肢体肿胀患者循环中的眼镜蛇毒液。早期清创和湿敷料处理是防止组织坏死延长和住院时间的建议。
{"title":"Taiwan cobra envenoming: serum venom concentration before and after specific treatment and relationship with debridement of necrotic wound tissue.","authors":"Chia-Cheng Wang,&nbsp;Chun-Hsiang Ou Yang,&nbsp;Chih-Po Hsu,&nbsp;Chien-Chun Liu,&nbsp;Jau-Song Yu,&nbsp;Chih-Hong Lo,&nbsp;Wen-Chih Fann,&nbsp;Yen-Chia Chen,&nbsp;Chih Chuan Lin","doi":"10.1590/1678-9199-JVATITD-2022-0027","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2022-0027","url":null,"abstract":"<p><strong>Background: </strong>Bivalent freeze-dried neurotoxic (FN) antivenom has been the primary treatment since the 1980s for Taiwan cobra (<i>Naja atra</i>) envenomation in Taiwan. However, envenomation-related wound necrosis is a significant problem after cobra snakebites. In the present study, we analyzed the changes in serum venom concentration before and after antivenom administration to discover their clinical implications and the surgical treatment options for wound necrosis.</p><p><strong>Methods: </strong>The patients were divided into limb swelling and wound necrosis groups. The clinical outcome was that swelling started to subside 12 hours after antivenom treatment in the first group. Serum venom concentrations before and after using antivenoms were measured to assess the antivenom's ability to neutralize the circulating cobra venom. The venom levels in wound wet dressing gauzes, blister fluids, and debrided tissues were also investigated to determine their clinical significance. We also observed the evolutional changes of wound necrosis and chose a better wound debridement timing.</p><p><strong>Results: </strong>We prospectively enrolled 15 Taiwan cobra snakebite patients. Males accounted for most of this study population (n = 11, 73%). The wound necrosis group received more antivenom doses than the limb swelling group (4; IQR:2-6 vs 1; IQR:1-2, p = 0.05), and less records of serum venom concentrations changed before/after antivenom use (p = 0.0079). The necrotic wound site may release venom into circulation and cause more severe envenomation symptoms. Antivenom can efficiently diminish limb swelling in cobra bite patients. However, antivenom cannot reduce wound necrosis. Patients with early debridement of wound necrosis had a better limb outcome, while late or without debridement may have long-term hospital stay and distal limb morbidity.</p><p><strong>Conclusions: </strong>Antivenom can efficiently eliminate the circulating cobra venom in limb swelling patients without wound necrosis. Early debridement of the bite site wound and wet dressing management are suggestions for preventing extended tissue necrosis and hospital stay.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20220027"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851669/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9153153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimalarial potential of Moringa oleifera Lam. (Moringaceae): A review of the ethnomedicinal, pharmacological, toxicological, and phytochemical evidence. 辣木的抗疟潜力。(辣木科):民族医学,药理学,毒理学和植物化学证据的综述。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2022-0079
José Jailson Lima Bezerra, Anderson Angel Vieira Pinheiro, Douglas Dourado

Several regions of the world frequently use the species Moringa oleifera Lam. (Moringaceae) in traditional medicine. This situation is even more common in African countries. Many literature reports point to the antimalarial potential of this species, indicating the efficacy of its chemical compounds against malaria-causing parasites of the genus Plasmodium. From this perspective, the present study reviews the ethnobotanical, pharmacological, toxicological, and phytochemical (flavonoids) evidence of M. oleifera, focusing on the treatment of malaria. Scientific articles were retrieved from Google Scholar, PubMed®, ScienceDirect®, and SciELO databases. Only articles published between 2002 and 2022 were selected. After applying the inclusion and exclusion criteria, this review used a total of 72 articles. These documents mention a large use of M. oleifera for the treatment of malaria in African and Asian countries. The leaves (63%) of this plant are the main parts used in the preparation of herbal medicines. The in vivo antimalarial activity of M. oleifera was confirmed through several studies using polar and nonpolar extracts, fractions obtained from the extracts, infusion, pellets, and oils obtained from this plant and tested in rodents infected by the following parasites of the genus Plasmodium: P. berghei, P. falciparum, P. yoelii, and P. chabaudi. Extracts obtained from M. oleifera showed no toxicity in preclinical tests. A total of 46 flavonoids were identified in the leaves and seeds of M. oleifera by different chromatography and mass spectrometry methods. Despite the scarcity of research on the antimalarial potential of compounds isolated from M. oleifera, the positive effects against malaria-causing parasites in previous studies are likely to correlate with the flavonoids that occur in this species.

世界上一些地区经常使用辣木(Moringa oleifera Lam)。传统医学中的辣木科植物。这种情况在非洲国家更为普遍。许多文献报告指出了该物种的抗疟疾潜力,表明其化合物对疟原虫属引起疟疾的寄生虫有效。从这个角度来看,本研究综述了油棕的民族植物学、药理学、毒理学和植物化学(类黄酮)证据,重点是治疗疟疾。科学文章从Google Scholar、PubMed®、ScienceDirect®和SciELO数据库中检索。只选择2002年至2022年间发表的文章。应用纳入和排除标准后,本综述共纳入72篇文献。这些文件提到在非洲和亚洲国家大量使用油橄榄来治疗疟疾。这种植物的叶子(63%)是制备草药的主要部分。通过使用极性和非极性提取物、提取物提取的部分、浸渍、颗粒和从该植物获得的油进行的几项研究,证实了油棕的体内抗疟活性,并在感染了以下疟原虫属寄生虫的啮齿动物中进行了测试:伯氏疟原虫、恶性疟原虫、约氏疟原虫和沙巴蒂疟原虫。从油橄榄中提取的提取物在临床前试验中显示没有毒性。采用不同的色谱和质谱分析方法,从油松叶和种子中鉴定出46种黄酮类化合物。尽管对从油棕中分离的化合物的抗疟疾潜力的研究很少,但在以前的研究中,对引起疟疾的寄生虫的积极作用可能与该物种中所含的类黄酮有关。
{"title":"Antimalarial potential of <i>Moringa oleifera</i> Lam. (Moringaceae): A review of the ethnomedicinal, pharmacological, toxicological, and phytochemical evidence.","authors":"José Jailson Lima Bezerra,&nbsp;Anderson Angel Vieira Pinheiro,&nbsp;Douglas Dourado","doi":"10.1590/1678-9199-JVATITD-2022-0079","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2022-0079","url":null,"abstract":"<p><p>Several regions of the world frequently use the species <i>Moringa oleifera</i> Lam. (Moringaceae) in traditional medicine. This situation is even more common in African countries. Many literature reports point to the antimalarial potential of this species, indicating the efficacy of its chemical compounds against malaria-causing parasites of the genus <i>Plasmodium</i>. From this perspective, the present study reviews the ethnobotanical, pharmacological, toxicological, and phytochemical (flavonoids) evidence of <i>M. oleifera</i>, focusing on the treatment of malaria. Scientific articles were retrieved from Google Scholar, PubMed<sup>®</sup>, ScienceDirect<sup>®</sup>, and SciELO databases. Only articles published between 2002 and 2022 were selected. After applying the inclusion and exclusion criteria, this review used a total of 72 articles. These documents mention a large use of <i>M. oleifera</i> for the treatment of malaria in African and Asian countries. The leaves (63%) of this plant are the main parts used in the preparation of herbal medicines. The <i>in vivo</i> antimalarial activity of <i>M. oleifera</i> was confirmed through several studies using polar and nonpolar extracts, fractions obtained from the extracts, infusion, pellets, and oils obtained from this plant and tested in rodents infected by the following parasites of the genus <i>Plasmodium</i>: <i>P. berghei, P. falciparum, P. yoelii</i>, and <i>P. chabaudi</i>. Extracts obtained from <i>M. oleifera</i> showed no toxicity in preclinical tests. A total of 46 flavonoids were identified in the leaves and seeds of <i>M. oleifera</i> by different chromatography and mass spectrometry methods. Despite the scarcity of research on the antimalarial potential of compounds isolated from <i>M. oleifera</i>, the positive effects against malaria-causing parasites in previous studies are likely to correlate with the flavonoids that occur in this species.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20220079"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9572401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
COVID-19 impacts on healthcare access in sub-Saharan Africa: an overview. 2019冠状病毒病对撒哈拉以南非洲获得医疗保健的影响:概述。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2023-0002
Jean-Philippe Chippaux

This overview aimed to describe the situation of healthcare access in sub-Saharan Africa, excluding South Africa, during the COVID-19 pandemic. A PubMed® search from March 31, 2020, to August 15, 2022, selected 116 articles. Healthcare access and consequences of COVID-19 were assessed based on comparisons with months before its onset or an identical season in previous years. A general reduction of healthcare delivery, associated with the decline of care quality, and closure of many specialty services were reported. The impact was heterogeneous in space and time, with an increase in urban areas at the beginning of the pandemic (March-June 2020). The return to normalcy was gradual from the 3rd quarter of 2020 until the end of 2021. The impact of COVID-19 on the health system and its use was attributed to (a) conjunctural factors resulting from government actions to mitigate the spread of the epidemic (containment, transportation restrictions, closures of businesses, and places of entertainment or worship); (b) structural factors related to the disruption of public and private facilities and institutions, in particular, the health system; and (c) individual factors linked to the increase in costs, impoverishment of the population, and fear of contamination or stigmatization, which discouraged patients from going to health centers. They have caused considerable socio-economic damage. Several studies emphasized some adaptability of the healthcare offer and resilience of the healthcare system, despite its unpreparedness, which explained a return to normal activities as early as 2022 while the COVID-19 epidemic persisted. There appears to be a strong disproportion between the moderate incidence and severity of COVID-19 in sub-Saharan Africa, and the dramatic impact on healthcare access. Several articles make recommendations for lowering the socioeconomic consequences of future epidemics to ensure better management of health issues.

本概述旨在描述2019冠状病毒病大流行期间撒哈拉以南非洲(不包括南非)的医疗保健获取情况。PubMed®检索从2020年3月31日到2022年8月15日,选择了116篇文章。根据与前几年发病前几个月或同一季节的比较,评估了COVID-19的医疗保健可及性和后果。据报道,与护理质量下降有关的保健服务普遍减少,许多专业服务机构关闭。影响在空间和时间上是不均匀的,在大流行开始时(2020年3月至6月),城市地区的影响有所增加。从2020年第三季度到2021年底,恢复正常是逐步的。COVID-19对卫生系统及其使用的影响归因于:(a)政府采取行动缓解疫情传播(控制、交通限制、关闭企业和娱乐或礼拜场所)所导致的时局因素;(b)与公共和私人设施和机构,特别是卫生系统中断有关的结构性因素;(c)与费用增加、人口贫困以及对污染或污名的恐惧有关的个人因素,这些因素使病人不愿去保健中心。它们造成了相当大的社会经济损害。几项研究强调了医疗保健服务的一些适应性和医疗保健系统的复原力,尽管它没有做好准备,这解释了早在2022年COVID-19疫情持续期间就恢复正常活动的原因。在撒哈拉以南非洲,COVID-19的中等发病率和严重程度与对获得医疗保健的巨大影响之间似乎存在严重的不相称。一些文章提出了降低未来流行病的社会经济后果的建议,以确保更好地管理卫生问题。
{"title":"COVID-19 impacts on healthcare access in sub-Saharan Africa: an overview.","authors":"Jean-Philippe Chippaux","doi":"10.1590/1678-9199-JVATITD-2023-0002","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2023-0002","url":null,"abstract":"<p><p>This overview aimed to describe the situation of healthcare access in sub-Saharan Africa, excluding South Africa, during the COVID-19 pandemic. A PubMed<sup>®</sup> search from March 31, 2020, to August 15, 2022, selected 116 articles. Healthcare access and consequences of COVID-19 were assessed based on comparisons with months before its onset or an identical season in previous years. A general reduction of healthcare delivery, associated with the decline of care quality, and closure of many specialty services were reported. The impact was heterogeneous in space and time, with an increase in urban areas at the beginning of the pandemic (March-June 2020). The return to normalcy was gradual from the 3<sup>rd</sup> quarter of 2020 until the end of 2021. The impact of COVID-19 on the health system and its use was attributed to (a) conjunctural factors resulting from government actions to mitigate the spread of the epidemic (containment, transportation restrictions, closures of businesses, and places of entertainment or worship); (b) structural factors related to the disruption of public and private facilities and institutions, in particular, the health system; and (c) individual factors linked to the increase in costs, impoverishment of the population, and fear of contamination or stigmatization, which discouraged patients from going to health centers. They have caused considerable socio-economic damage. Several studies emphasized some adaptability of the healthcare offer and resilience of the healthcare system, despite its unpreparedness, which explained a return to normal activities as early as 2022 while the COVID-19 epidemic persisted. There appears to be a strong disproportion between the moderate incidence and severity of COVID-19 in sub-Saharan Africa, and the dramatic impact on healthcare access. Several articles make recommendations for lowering the socioeconomic consequences of future epidemics to ensure better management of health issues.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20230002"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9805962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Glutamine ameliorates Bungarus multicinctus venom-induced lung and heart injury through HSP70: NF-κB p65 and P53/PUMA signaling pathways involved. 谷氨酰胺通过参与HSP70: NF-κB p65和P53/PUMA信号通路改善多角沙鼠毒液诱导的肺和心脏损伤。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2022-0080
Yalan Li, Zhezhe Guan, Shaocong Hu, Zhi Huang, Dongling He, Xiaoyang Cheng, Tianlin Song, Caifeng Mo, Manqi Xiao, Yue Huang, Yuanmei Wei, Yi Zhou, Xuerong Zhang, Ming Liao

Background: Bungarus multicinctus is one of the most dangerous venomous snakes prone to cardiopulmonary damage with extremely high mortality. In our previous work, we found that glutamine (Gln) and glutamine synthetase (GS) in pig serum were significantly reduced after Bungarus multicinctus bite. In the present study, to explore whether there is a link between the pathogenesis of cardiopulmonary injury and Gln metabolic changes induced by Bungarus multicinctus venom. We investigated the effect of Gln supplementation on the lung and heart function after snakebite.

Methods: We supplemented different concentrations of Gln to mice that were envenomated by Bungarus multicinctus to observe the biological behavior, survival rate, hematological and pathological changes. Gln was supplemented immediately or one hour after the venom injection, and then changes in Gln metabolism were analyzed. Subsequently, to further explore the protective mechanism of glutamine on tissue damage, we measured the expression of heat-shock protein70 (HSP70), NF-κB P65, P53/PUMA by western blotting and real-time polymerase in the lung and heart.

Results: Gln supplementation delayed the envenoming symptoms, reduced mortality, and alleviated the histopathological changes in the heart and lung of mice bitten by Bungarus multicinctus. Additionally, Gln increased the activity of glutamine synthetase (GS), glutamate dehydrogenase (GDH) and glutaminase (GLS) in serum. It also balanced the transporter SLC7A11 expression in heart and lung tissues. Bungarus multicinctus venom induced the NF-κB nuclear translocation in the lung, while the HO-1 expression was suppressed. At the same time, venom activated the P53/PUMA signaling pathway and the BAX expression in the heart. Gln treatment reversed the above phenomenon and increased HSP70 expression.

Conclusion: Gln alleviated the glutamine metabolism disorder and cardiopulmonary damage caused by Bungarus multicinctus venom. It may protect lungs and heart against venom by promoting the expression of HSP70, inhibiting the activation of NF-κB and P53/PUMA, thereby delaying the process of snake venom and reducing mortality. The present results indicate that Gln could be a potential treatment for Bungarus multicinctus bite.

背景:多纹蛇是最危险的毒蛇之一,易造成心肺损伤,死亡率极高。在我们之前的工作中,我们发现在多刺兔咬伤后猪血清中的谷氨酰胺(Gln)和谷氨酰胺合成酶(GS)显著降低。在本研究中,我们将探讨多刺沙鼠毒液引起的Gln代谢变化与心肺损伤的发病机制是否存在联系。我们研究了补充谷氨酰胺对蛇咬伤后肺和心脏功能的影响。方法:以不同浓度的谷氨酰胺(Gln)给毒鼠,观察其生物学行为、存活率、血液学及病理变化。即刻或注射后1小时补充Gln,分析Gln代谢变化。随后,为了进一步探讨谷氨酰胺对组织损伤的保护机制,我们采用western blotting和实时聚合酶检测肺和心脏组织中热休克蛋白70 (HSP70)、NF-κB P65、P53/PUMA的表达。结果:补充谷氨酰胺可延缓多刺沙鼠咬伤小鼠的中毒症状,降低死亡率,减轻其心肺组织病理改变。谷氨酰胺可提高血清谷氨酰胺合成酶(GS)、谷氨酸脱氢酶(GDH)和谷氨酰胺酶(GLS)活性。它还平衡了转运体SLC7A11在心肺组织中的表达。蛇毒诱导肺组织NF-κB核易位,抑制HO-1的表达。同时,毒液激活了P53/PUMA信号通路和心脏中BAX的表达。Gln处理逆转了上述现象,增加了HSP70的表达。结论:谷氨酰胺可减轻毒鼠引起的谷氨酰胺代谢紊乱和心肺损伤。它可能通过促进HSP70的表达,抑制NF-κB和P53/PUMA的激活,从而延缓蛇毒的过程,降低死亡率,从而保护肺和心脏免受蛇毒的侵害。本研究结果表明,谷氨酰胺可能是一种潜在的治疗多爪沙鼠咬伤的药物。
{"title":"Glutamine ameliorates <i>Bungarus multicinctus</i> venom-induced lung and heart injury through HSP70: NF-κB p65 and P53/PUMA signaling pathways involved.","authors":"Yalan Li,&nbsp;Zhezhe Guan,&nbsp;Shaocong Hu,&nbsp;Zhi Huang,&nbsp;Dongling He,&nbsp;Xiaoyang Cheng,&nbsp;Tianlin Song,&nbsp;Caifeng Mo,&nbsp;Manqi Xiao,&nbsp;Yue Huang,&nbsp;Yuanmei Wei,&nbsp;Yi Zhou,&nbsp;Xuerong Zhang,&nbsp;Ming Liao","doi":"10.1590/1678-9199-JVATITD-2022-0080","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2022-0080","url":null,"abstract":"<p><strong>Background: </strong><i>Bungarus multicinctus</i> is one of the most dangerous venomous snakes prone to cardiopulmonary damage with extremely high mortality. In our previous work, we found that glutamine (Gln) and glutamine synthetase (GS) in pig serum were significantly reduced after <i>Bungarus multicinctus</i> bite. In the present study, to explore whether there is a link between the pathogenesis of cardiopulmonary injury and Gln metabolic changes induced by <i>Bungarus multicinctus</i> venom. We investigated the effect of Gln supplementation on the lung and heart function after snakebite.</p><p><strong>Methods: </strong>We supplemented different concentrations of Gln to mice that were envenomated by <i>Bungarus multicinctus</i> to observe the biological behavior, survival rate, hematological and pathological changes. Gln was supplemented immediately or one hour after the venom injection, and then changes in Gln metabolism were analyzed. Subsequently, to further explore the protective mechanism of glutamine on tissue damage, we measured the expression of heat-shock protein70 (HSP70), NF-κB P65, P53/PUMA by western blotting and real-time polymerase in the lung and heart.</p><p><strong>Results: </strong>Gln supplementation delayed the envenoming symptoms, reduced mortality, and alleviated the histopathological changes in the heart and lung of mice bitten by <i>Bungarus multicinctus</i>. Additionally, Gln increased the activity of glutamine synthetase (GS), glutamate dehydrogenase (GDH) and glutaminase (GLS) in serum. It also balanced the transporter SLC7A11 expression in heart and lung tissues. <i>Bungarus multicinctus</i> venom induced the NF-κB nuclear translocation in the lung, while the HO-1 expression was suppressed. At the same time, venom activated the P53/PUMA signaling pathway and the BAX expression in the heart. Gln treatment reversed the above phenomenon and increased HSP70 expression.</p><p><strong>Conclusion: </strong>Gln alleviated the glutamine metabolism disorder and cardiopulmonary damage caused by <i>Bungarus multicinctus</i> venom. It may protect lungs and heart against venom by promoting the expression of HSP70, inhibiting the activation of NF-κB and P53/PUMA, thereby delaying the process of snake venom and reducing mortality. The present results indicate that Gln could be a potential treatment for <i>Bungarus multicinctus</i> bite.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20220080"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334810/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9819992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Propolis anti-inflammatory effects on MAGE-1 and retinoic acid-treated dendritic cells and on Th1 and T regulatory cells. 蜂胶对MAGE-1和维甲酸处理的树突状细胞以及Th1和T调节细胞的抗炎作用。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2022-0044
Karina Basso Santiago, Bruno José Conti, Eliza de Oliveira Cardoso, Fernanda Lopes Conte, Karen Ingrid Tasca, Graziela Gorete Romagnoli, Marjorie de Assis Golim, Maria Tereza Cruz, José Maurício Sforcin
Abstract Background: Propolis exhibits huge potential in the pharmaceutical industry. In the present study, its effects were investigated on dendritic cells (DCs) stimulated with a tumor antigen (MAGE-1) and retinoic acid (RA) and on T lymphocytes to observe a possible differential activation of T lymphocytes, driving preferentially to Th1 or Treg cells. Methods: Cell viability, lymphocyte proliferation, gene expression (T-bet and FoxP3), and cytokine production by DCs (TNF-α, IL-10, IL-6 and IL-1β) and lymphocytes (IFN-γ and TGF-β) were analyzed. Results: MAGE-1 and RA alone or in combination with propolis inhibited TNF-α production and induced a higher lymphoproliferation compared to control, while MAGE-1 + propolis induced IL-6 production. Propolis in combination with RA induced FoxP3 expression. MAGE-1 induced IFN-γ production while propolis inhibited it, returning to basal levels. RA inhibited TGF-β production, what was counteracted by propolis. Conclusion: Propolis affected immunological parameters inhibiting pro-inflammatory cytokines and favoring the regulatory profile, opening perspectives for the control of inflammatory conditions.
背景:蜂胶在制药行业显示出巨大的潜力。在本研究中,研究了其对肿瘤抗原(MAGE-1)和视黄酸(RA)刺激的树突状细胞(DCs)和T淋巴细胞的影响,以观察T淋巴细胞可能的差异活化,优先驱动Th1或Treg细胞。方法:分析细胞活力、淋巴细胞增殖、基因表达(T-bet、FoxP3)及dc (TNF-α、IL-10、IL-6、IL-1β)和淋巴细胞(IFN-γ、TGF-β)细胞因子的产生。结果:与对照组相比,MAGE-1和RA单独或联合蜂胶抑制TNF-α的产生,诱导更高的淋巴细胞增殖,而MAGE-1 +蜂胶诱导IL-6的产生。蜂胶联合RA诱导FoxP3表达。MAGE-1诱导IFN-γ产生,蜂胶抑制IFN-γ产生,使其恢复到基础水平。RA抑制TGF-β的产生,蜂胶抵消了这一作用。结论:蜂胶影响免疫参数,抑制促炎细胞因子,有利于炎症的调控,为炎症的控制开辟了新的思路。
{"title":"Propolis anti-inflammatory effects on MAGE-1 and retinoic acid-treated dendritic cells and on Th1 and T regulatory cells.","authors":"Karina Basso Santiago,&nbsp;Bruno José Conti,&nbsp;Eliza de Oliveira Cardoso,&nbsp;Fernanda Lopes Conte,&nbsp;Karen Ingrid Tasca,&nbsp;Graziela Gorete Romagnoli,&nbsp;Marjorie de Assis Golim,&nbsp;Maria Tereza Cruz,&nbsp;José Maurício Sforcin","doi":"10.1590/1678-9199-JVATITD-2022-0044","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2022-0044","url":null,"abstract":"Abstract Background: Propolis exhibits huge potential in the pharmaceutical industry. In the present study, its effects were investigated on dendritic cells (DCs) stimulated with a tumor antigen (MAGE-1) and retinoic acid (RA) and on T lymphocytes to observe a possible differential activation of T lymphocytes, driving preferentially to Th1 or Treg cells. Methods: Cell viability, lymphocyte proliferation, gene expression (T-bet and FoxP3), and cytokine production by DCs (TNF-α, IL-10, IL-6 and IL-1β) and lymphocytes (IFN-γ and TGF-β) were analyzed. Results: MAGE-1 and RA alone or in combination with propolis inhibited TNF-α production and induced a higher lymphoproliferation compared to control, while MAGE-1 + propolis induced IL-6 production. Propolis in combination with RA induced FoxP3 expression. MAGE-1 induced IFN-γ production while propolis inhibited it, returning to basal levels. RA inhibited TGF-β production, what was counteracted by propolis. Conclusion: Propolis affected immunological parameters inhibiting pro-inflammatory cytokines and favoring the regulatory profile, opening perspectives for the control of inflammatory conditions.","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20220044"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851646/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9153152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cone snail species off the Brazilian coast and their venoms: a review and update. 巴西海岸的锥螺种类及其毒液:回顾与更新。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2022-0052
Helena B Fiorotti, Suely G Figueiredo, Fabiana V Campos, Daniel C Pimenta

The genus Conus includes over 900 species of marine invertebrates known as cone snails, whose venoms are among the most powerful described so far. This potency is mainly due to the concerted action of hundreds of small bioactive peptides named conopeptides, which target different ion channels and membrane receptors and thus interfere with crucial physiological processes. By swiftly harpooning and injecting their prey and predators with such deadly cocktails, the slow-moving cone snails guarantee their survival in the harsh, competitive marine environment. Each cone snail species produces a unique venom, as the mature sequences of conopeptides from the venoms of different species share very little identity. This biochemical diversity, added to the numerous species and conopeptides contained in their venoms, results in an immense biotechnological and therapeutic potential, still largely unexplored. That is especially true regarding the bioprospection of the venoms of cone snail species found off the Brazilian coast - a region widely known for its biodiversity. Of the 31 species described in this region so far, only four - Conus cancellatus, Conus regius, Conus villepinii, and Conus ermineus - have had their venoms partially characterized, and, although many bioactive molecules have been identified, only a few have been actually isolated and studied. In addition to providing an overview on all the cone snail species found off the Brazilian coast to date, this review compiles the information on the structural and pharmacological features of conopeptides and other molecules identified in the venoms of the four aforementioned species, paving the way for future studies.

圆锥螺属包括900多种被称为圆锥螺的海洋无脊椎动物,其毒液是迄今为止所描述的最强大的。这种效力主要是由于数百种被称为conopeptides的小生物活性肽的协同作用,它们靶向不同的离子通道和膜受体,从而干扰关键的生理过程。通过迅速用鱼叉向猎物和捕食者注射这种致命的鸡尾酒,缓慢移动的锥螺确保了它们在严酷、竞争激烈的海洋环境中生存下来。每一种锥螺都产生一种独特的毒液,因为来自不同物种毒液的成熟肽序列几乎没有相同之处。这种生物化学的多样性,再加上它们毒液中所含的众多物种和con多肽,产生了巨大的生物技术和治疗潜力,但在很大程度上仍未得到开发。对于在巴西海岸发现的锥螺物种的毒液的生物前景来说,这一点尤其正确——巴西海岸是一个以生物多样性闻名的地区。到目前为止,在该地区所描述的31种圆锥虫中,只有4种圆锥虫(Conus cancellatus, Conus regius, Conus villepinii和Conus ermineus)的毒液被部分鉴定出来,尽管已经鉴定出许多生物活性分子,但真正被分离和研究的只有少数。除了对迄今为止在巴西海岸发现的所有锥螺物种进行概述外,本综述还汇编了上述四种物种毒液中鉴定的con多肽和其他分子的结构和药理特征信息,为今后的研究铺平了道路。
{"title":"Cone snail species off the Brazilian coast and their venoms: a review and update.","authors":"Helena B Fiorotti,&nbsp;Suely G Figueiredo,&nbsp;Fabiana V Campos,&nbsp;Daniel C Pimenta","doi":"10.1590/1678-9199-JVATITD-2022-0052","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2022-0052","url":null,"abstract":"<p><p>The genus <i>Conus</i> includes over 900 species of marine invertebrates known as cone snails, whose venoms are among the most powerful described so far. This potency is mainly due to the concerted action of hundreds of small bioactive peptides named conopeptides, which target different ion channels and membrane receptors and thus interfere with crucial physiological processes. By swiftly harpooning and injecting their prey and predators with such deadly cocktails, the slow-moving cone snails guarantee their survival in the harsh, competitive marine environment. Each cone snail species produces a unique venom, as the mature sequences of conopeptides from the venoms of different species share very little identity. This biochemical diversity, added to the numerous species and conopeptides contained in their venoms, results in an immense biotechnological and therapeutic potential, still largely unexplored. That is especially true regarding the bioprospection of the venoms of cone snail species found off the Brazilian coast - a region widely known for its biodiversity. Of the 31 species described in this region so far, only four - <i>Conus cancellatus</i>, <i>Conus regius</i>, <i>Conus villepinii</i>, and <i>Conus ermineus</i> - have had their venoms partially characterized, and, although many bioactive molecules have been identified, only a few have been actually isolated and studied. In addition to providing an overview on all the cone snail species found off the Brazilian coast to date, this review compiles the information on the structural and pharmacological features of conopeptides and other molecules identified in the venoms of the four aforementioned species, paving the way for future studies.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20220052"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897318/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10689694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comparing modified Lee and White method against 20-minute whole blood clotting test as bedside coagulation screening test in snake envenomation victims. 改良Lee和White法与20分钟全血凝血试验作为毒蛇中毒患者床边凝血筛查试验的比较。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2022-0088
Appu Suseel, Siju V Abraham, Sarah Paul, Maglin Monica Lisa Tomy, Aboobacker Mohamed Rafi

Background: Twenty-minute whole blood clotting test (20WBCT) and Modified Lee and White (MLW) method are the most routinely employed bedside tests for detecting coagulopathic snake envenomation. Our study compared the diagnostic utility of MLW and 20WBCT for snakebite victims at a tertiary care hospital in Central Kerala, South India.

Methods: This single-center study recruited 267 patients admitted with snake bites. 20WBCT and MLW were performed simultaneously at admission along with the measurement of Prothrombin Time (PT). The diagnostic utility of 20WBCT and MLW was determined by comparing the sensitivity (Sn), specificity (Sp), positive and negative predictive values, likelihood ratios, and accuracy at admission with an INR value > 1.4.

Results: Out of 267 patients, 20 (7.5%) patients had VICC. Amongst those who had venom-induced consumption coagulopathy (VICC), MLW was prolonged for 17 patients, (Sn 85% 95% confidence interval [CI]: 61.1-96.0) whereas 20WBCT was abnormal for 11 patients (Sn 55%, 95% CI: 32.04-76.17). MLW and 20WBCT were falsely positive for the same patient (Sp 99.6%, 95% CI: 97.4-99.9%).

Conclusion: MLW is more sensitive than 20WBCT to detect coagulopathy at the bedside amongst snakebite victims. However, further studies are necessary for standardizing bedside coagulation tests in snakebite cases.

背景:20分钟全血凝血试验(20WBCT)和改良Lee and White (MLW)法是检测凝血障碍蛇中毒最常用的床边检查方法。本研究比较了印度南部喀拉拉邦中部一家三级医院的MLW和20WBCT对蛇咬伤患者的诊断效用。方法:本研究招募了267例因蛇咬伤入院的患者。入院时同时行wbct和MLW,并测定凝血酶原时间(PT)。通过比较20WBCT和MLW的敏感性(Sn)、特异性(Sp)、阳性和阴性预测值、似然比和入院时INR值> 1.4的准确性来确定其诊断价值。结果:267例患者中,20例(7.5%)患者有VICC。在有毒液诱导的消耗性凝血功能障碍(VICC)的患者中,17例患者的MLW延长(Sn 85% 95%可信区间[CI]: 61.1-96.0),而11例患者的20WBCT异常(Sn 55%, 95% CI: 32.04-76.17)。同一患者的MLW和20WBCT假阳性(Sp: 99.6%, 95% CI: 97.4-99.9%)。结论:MLW对蛇咬伤患者床边凝血功能的检测灵敏度高于20WBCT。然而,规范蛇咬伤患者床边凝血试验仍需进一步研究。
{"title":"Comparing modified Lee and White method against 20-minute whole blood clotting test as bedside coagulation screening test in snake envenomation victims.","authors":"Appu Suseel,&nbsp;Siju V Abraham,&nbsp;Sarah Paul,&nbsp;Maglin Monica Lisa Tomy,&nbsp;Aboobacker Mohamed Rafi","doi":"10.1590/1678-9199-JVATITD-2022-0088","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2022-0088","url":null,"abstract":"<p><strong>Background: </strong>Twenty-minute whole blood clotting test (20WBCT) and Modified Lee and White (MLW) method are the most routinely employed bedside tests for detecting coagulopathic snake envenomation. Our study compared the diagnostic utility of MLW and 20WBCT for snakebite victims at a tertiary care hospital in Central Kerala, South India.</p><p><strong>Methods: </strong>This single-center study recruited 267 patients admitted with snake bites. 20WBCT and MLW were performed simultaneously at admission along with the measurement of Prothrombin Time (PT). The diagnostic utility of 20WBCT and MLW was determined by comparing the sensitivity (Sn), specificity (Sp), positive and negative predictive values, likelihood ratios, and accuracy at admission with an INR value > 1.4.</p><p><strong>Results: </strong>Out of 267 patients, 20 (7.5%) patients had VICC. Amongst those who had venom-induced consumption coagulopathy (VICC), MLW was prolonged for 17 patients, (Sn 85% 95% confidence interval [CI]: 61.1-96.0) whereas 20WBCT was abnormal for 11 patients (Sn 55%, 95% CI: 32.04-76.17). MLW and 20WBCT were falsely positive for the same patient (Sp 99.6%, 95% CI: 97.4-99.9%).</p><p><strong>Conclusion: </strong>MLW is more sensitive than 20WBCT to detect coagulopathy at the bedside amongst snakebite victims. However, further studies are necessary for standardizing bedside coagulation tests in snakebite cases.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20220088"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278964/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9709683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproducibility of double agar gel immunodiffusion test using stored serum and plasma from paracoccidioidomycosis patients. 双琼脂凝胶免疫扩散试验对副球孢子菌病患者血清和血浆的重复性研究。
IF 2.4 3区 医学 Q4 TOXICOLOGY Pub Date : 2023-01-01 DOI: 10.1590/1678-9199-JVATITD-2022-0045
Karina Andressa Tomazini, Beatriz Aparecida Soares Pereira, Tatiane Fernanda Sylvestre, Ricardo de Souza Cavalcante, Lídia Raquel de Carvalho, Rinaldo Poncio Mendes

Background: Serological evaluation performed by double agar gel immunodiffusion test (DID) is used for diagnosis, evaluation of severity, management of paracoccidioidomycosis patients, and development of new clinical studies. For these reasons, the Botucatu Medical School of UNESP maintains a serum bank at the Experimental Research Unit with patient clinical data. This study aimed to evaluate the influence of the freeze-thaw cycle and different blood matrices on the titration of circulating antibodies.

Methods: The study included 207 patients with confirmed (etiology-demonstrated) or probable (serology-demonstrated) paracoccidioidomycosis, and DID was performed with culture filtrate from Paracoccidioides brasiliensis B339 as antigen. First experiment: the antibody levels were determined in serum samples from 160 patients with the chronic form and 20 with the acute/subacute form, stored at -80oC for more than six months. Second experiment: titers of 81 samples of serum and plasma with ethylenediaminetetraacetic acid (EDTA) or heparin, from 27 patients, were compared according to matrix and effect of storage at -20oC for up to six months. Differences of titers higher than one dilution were considered discordant.

Results: First experiment: test and retest presented concordant results in serum stored for up to three years, and discordant titers in low incidence in storage for four to six years but high incidence when stored for more than six years, including conversion from reagent test to non-reagent retest. Second experiment: serum, plasma-EDTA and plasma-heparin samples showed concordant titers, presenting direct correlation, with no interference of storage for up to six months.

Conclusions: Storage at -80oC for up to six years has no or little influence on the serum titers determined by DID, permitting its safe use in studies depending on this parameter. The concordant titrations in different blood matrices demonstrated that the plasma can be used for immunodiffusion test in paracoccidioidomycosis, with stability for at least six months after storage at -20oC.

背景:双琼脂凝胶免疫扩散试验(DID)的血清学评价可用于副球孢子菌病的诊断、严重程度评估、治疗以及开展新的临床研究。由于这些原因,UNESP博图卡图医学院在实验研究股设有一个血清库,储存病人临床数据。本研究旨在评价冻融循环和不同血液基质对循环抗体滴定的影响。方法:研究纳入207例确诊(病原学证明)或可能(血清学证明)副球孢子菌病患者,以巴西副球孢子虫B339培养滤液为抗原进行DID。第一个实验:测定160例慢性型和20例急性/亚急性型患者血清中抗体水平,在-80℃保存6个月以上。第二项实验:比较27例患者81份含乙二胺四乙酸(EDTA)或肝素的血清和血浆样品,根据基质和-20℃保存长达6个月的效果进行滴度比较。高于一个稀释度的滴度差异被认为是不一致的。结果:第一次实验:保存3年以内的血清检测与复验结果一致,保存4 ~ 6年的血清滴度不一致发生率低,保存6年以上的血清滴度不一致发生率高,包括试剂检测向非试剂复验的转换。实验二:血清、血浆edta、血浆肝素样品滴度一致,呈直接相关性,保存6个月不受干扰。结论:在-80℃下储存长达6年对DID测定的血清滴度没有或很少影响,允许其在依赖于该参数的研究中安全使用。在不同血液基质中的一致性滴定结果表明,血浆可用于副球孢子菌病的免疫扩散试验,在-20℃下保存后稳定性至少为6个月。
{"title":"Reproducibility of double agar gel immunodiffusion test using stored serum and plasma from paracoccidioidomycosis patients.","authors":"Karina Andressa Tomazini,&nbsp;Beatriz Aparecida Soares Pereira,&nbsp;Tatiane Fernanda Sylvestre,&nbsp;Ricardo de Souza Cavalcante,&nbsp;Lídia Raquel de Carvalho,&nbsp;Rinaldo Poncio Mendes","doi":"10.1590/1678-9199-JVATITD-2022-0045","DOIUrl":"https://doi.org/10.1590/1678-9199-JVATITD-2022-0045","url":null,"abstract":"<p><strong>Background: </strong>Serological evaluation performed by double agar gel immunodiffusion test (DID) is used for diagnosis, evaluation of severity, management of paracoccidioidomycosis patients, and development of new clinical studies. For these reasons, the Botucatu Medical School of UNESP maintains a serum bank at the Experimental Research Unit with patient clinical data. This study aimed to evaluate the influence of the freeze-thaw cycle and different blood matrices on the titration of circulating antibodies.</p><p><strong>Methods: </strong>The study included 207 patients with confirmed (etiology-demonstrated) or probable (serology-demonstrated) paracoccidioidomycosis, and DID was performed with culture filtrate from <i>Paracoccidioides brasiliensis</i> B339 as antigen. First experiment: the antibody levels were determined in serum samples from 160 patients with the chronic form and 20 with the acute/subacute form, stored at -80<sup>o</sup>C for more than six months. Second experiment: titers of 81 samples of serum and plasma with ethylenediaminetetraacetic acid (EDTA) or heparin, from 27 patients, were compared according to matrix and effect of storage at -20<sup>o</sup>C for up to six months. Differences of titers higher than one dilution were considered discordant.</p><p><strong>Results: </strong>First experiment: test and retest presented concordant results in serum stored for up to three years, and discordant titers in low incidence in storage for four to six years but high incidence when stored for more than six years, including conversion from reagent test to non-reagent retest. Second experiment: serum, plasma-EDTA and plasma-heparin samples showed concordant titers, presenting direct correlation, with no interference of storage for up to six months.</p><p><strong>Conclusions: </strong>Storage at -80<sup>o</sup>C for up to six years has no or little influence on the serum titers determined by DID, permitting its safe use in studies depending on this parameter. The concordant titrations in different blood matrices demonstrated that the plasma can be used for immunodiffusion test in paracoccidioidomycosis, with stability for at least six months after storage at -20<sup>o</sup>C.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"29 ","pages":"e20220045"},"PeriodicalIF":2.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10544834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Venomous Animals and Toxins Including Tropical Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1